Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Screening and behavioral management: medication overuse headache--the complex case.

Alvin E Lake1

  • 1Michigan Head Pain and Neurological Institute, Ann Arbor, MI 48104, USA.

Headache
|January 11, 2008
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical aspects of medication overuse headaches.

Headache·2013
Same author

A practice guide for continuous opioid therapy for refractory daily headache: patient selection, physician requirements, and treatment monitoring.

Headache·2010
Same author

Defining refractory migraine: results of the RHSIS Survey of American Headache Society members.

Headache·2009
Same author

Comprehensive inpatient treatment of refractory chronic daily headache.

Headache·2009
Same author

Refractory migraine: introductory editorial.

Headache·2008
Same author

Continuous opioid therapy (COT) is rarely advisable for refractory chronic daily headache: limited efficacy, risks, and proposed guidelines.

Headache·2008
Same journal

Biochemical profiling and symptomatology of androgen deficiency in males with cluster headache: A prospective case-control study.

Headache·2026
Same journal

Thiamine deficiency in patients with chronic migraine: A case-control study.

Headache·2026
Same journal

Potential association of cluster headache with certain COVID-19 vaccines: An assessment from the pharmacovigilance databases.

Headache·2026
Same journal

Potential role of tirzepatide, a dual GLP-1 and GIP receptor agonist, for preventive treatment of migraine: A case series.

Headache·2026
Same journal

Adverse childhood experiences, migraine, and adverse pregnancy outcomes among teenage mothers.

Headache·2026
Same journal

Weight loss with atogepant in the long-term treatment of migraine: An interim analysis of a safety endpoint from a phase 3, multicenter, open-label, 156-week extension study.

Headache·2026
See all related articles

New criteria broaden chronic migraine diagnosis, no longer requiring headache resolution for medication overuse headache (MOH). Complex MOH involves factors like opioid use and relapse, highlighting management challenges.

Area of Science:

  • Neurology
  • Headache Medicine
  • Pharmacology

Background:

  • The International Headache Society updated criteria for chronic migraine diagnosis.
  • Medication overuse headache (MOH) is now defined more broadly, not requiring complete headache resolution.
  • MOH is classified into simple (Type I) and complex (Type II) forms.

Purpose of the Study:

  • To introduce the revised diagnostic criteria for chronic migraine and medication overuse headache (MOH).
  • To describe the characteristics and risk factors associated with complex MOH (Type II).
  • To illustrate the long-term management challenges of complex MOH through a case study.

Main Methods:

  • Review of the International Headache Society's updated appendix criteria for chronic migraine.

Related Experiment Videos

  • Classification of MOH into simple and complex types based on diagnostic features.
  • Presentation of a 20-year case illustration of complex MOH management.

    • Main Results:

    • The updated criteria allow MOH diagnosis without requiring headache resolution or return to a previous pattern.
    • Complex MOH (Type II) is associated with daily opioid/analgesic use, multisourcing, psychiatric comorbidities, and relapse history.
    • Risk factors for MOH include daily opioid use for other conditions, psychiatric issues, substance use history, and family history of substance disorders.
    • High relapse rates (up to 71% at 4 years) are observed in analgesic overusers.

    Conclusions:

    • The revised criteria facilitate a broader diagnosis of MOH in chronic migraine patients.
    • Complex MOH presents significant management challenges due to associated comorbidities and relapse potential.
    • Effective screening and long-term management strategies are crucial for patients with complex MOH.